Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

被引:15
作者
Choi, Chel Hun [1 ]
Song, Sang Yong [2 ]
Kang, Heeseok [1 ]
Lee, Yoo-Young [1 ]
Kim, Chul-Jung [1 ]
Lee, Jeong-Won [1 ]
Kim, Tae-Joong [1 ]
Kim, Byoung-Gie [1 ]
Lee, Je-Ho [1 ]
Bae, Duk-Soo [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Obstet & Gynecol, Samsung Med Ctr, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul 135710, South Korea
关键词
bulky cervical carcinoma; immunohistochemistry; p-STAT3; SQUAMOUS-CELL CARCINOMA; CONSTITUTIVE ACTIVATION; MOLECULAR TARGETS; CANCER CELLS; TRANSCRIPTIONAL CONTROL; SIGNAL TRANSDUCERS; GASTRIC-CANCER; PHASE-II; STAT3; EXPRESSION;
D O I
10.1111/j.1447-0756.2009.01131.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To better predict treatment responses for managing bulky cervical carcinoma with neoadjuvant chemotherapy (NAC). Methods: The expression of p-STAT3 was analyzed by immunohistochemistry using paraffin-embedded pretreatment cervical biopsy tissues. The study included 29 patients with bulky IB to IIA cervical squamous cell carcinoma treated with NAC. Results: Twenty (69.0%) of 29 patients were scored as p-STAT3-positive. Pathological response to chemotherapy (complete response or residual tumor with less than 3 mm stromal invasion) was observed in eight patients (27.6%). The p-STAT3-positive patients had a longer disease-free survival compared to p-STAT3-negative patients (P = 0.03), though they had more frequent clinical nodal involvement (P = 0.046). Conclusion: Pretreatment assessment of p-STAT3 expression may provide additional information for the identification of patients with cervical cancer who have a favorable prognosis.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 38 条
[1]   STATs in oncogenesis [J].
Bowman, T ;
Garcia, R ;
Turkson, J ;
Jove, R .
ONCOGENE, 2000, 19 (21) :2474-2488
[2]   The role of STATs in transcriptional control and their impact on cellular function [J].
Bromberg, J ;
Darnell, JE .
ONCOGENE, 2000, 19 (21) :2468-2473
[3]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[4]   Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: The SNAP01 (studio neo-adjuvante portio) Italian collaborative study [J].
Buda, A ;
Fossati, R ;
Colombo, N ;
Fei, F ;
Floriani, I ;
Alletti, DG ;
Katsaros, D ;
Landoni, F ;
Lissoni, A ;
Malzoni, C ;
Sartori, E ;
Scollo, P ;
Torri, V ;
Zola, P ;
Mangioni, C .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4137-4145
[5]  
Buettner R, 2002, CLIN CANCER RES, V8, P945
[6]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[7]   Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3 [J].
Chapman, RS ;
Lourenco, PC ;
Tonner, E ;
Elint, DJ ;
Selbert, S ;
Takeda, K ;
Akira, S ;
Clarke, AR ;
Watson, CJ .
GENES & DEVELOPMENT, 1999, 13 (19) :2604-2616
[8]   Stat3 activation in human endometrial and cervical cancers [J].
Chen, C-L ;
Hsieh, F-C ;
Lieblein, J. C. ;
Brown, J. ;
Chan, C. ;
Wallace, J. A. ;
Cheng, G. ;
Hall, B. M. ;
Lin, J. .
BRITISH JOURNAL OF CANCER, 2007, 96 (04) :591-599
[9]   Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma [J].
Choi, Chel Hun ;
Kim, Tae-Joong ;
Lee, Jeong-Won ;
Kim, Byoung-Gie ;
Lee, Je-Ho ;
Bae, Duk-Soo .
GYNECOLOGIC ONCOLOGY, 2007, 104 (01) :64-69
[10]   Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy [J].
Choi, Chel Hun ;
Song, Sang Yong ;
Choi, Jung-Joo ;
Park, Young Ae ;
Kang, Heeseok ;
Kim, Tae-Joong ;
Lee, Jeong-Won ;
Kim, Byoung-Gie ;
Lee, Je-Ho ;
Bae, Duk-Soo .
BMC CANCER, 2008, 8 (1)